Biosensors Plans 1,600-Patient U.S. Trial Of BioMatrix DES For 2006
This article was originally published in The Gray Sheet
Executive Summary
Biosensors plans to file an investigational device exemption for a 1,600-patient trial of its BioMatrix Biolimus A9-eluting stent in early 2006